These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
466 related items for PubMed ID: 23951599
1. Trauma and severe bleeding. Tranexamic acid within one hour to reduce mortality. Prescrire Int; 2013 Jul; 22(140):189-90. PubMed ID: 23951599 [Abstract] [Full Text] [Related]
3. The current place of tranexamic acid in the management of bleeding. Hunt BJ. Anaesthesia; 2015 Jan; 70 Suppl 1():50-3, e18. PubMed ID: 25440395 [Abstract] [Full Text] [Related]
4. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2) A randomised, placebo-controlled trial. Williams-Johnson JA, McDonald AH, Strachan GG, Williams EW. West Indian Med J; 2010 Dec; 59(6):612-24. PubMed ID: 21702233 [Abstract] [Full Text] [Related]
7. Should antifibrinolytics be given in all patients with trauma? Levi M. Curr Opin Anaesthesiol; 2012 Jun; 25(3):385-8. PubMed ID: 22459985 [Abstract] [Full Text] [Related]
8. Development and validation of a prognostic model to predict death in patients with traumatic bleeding, and evaluation of the effect of tranexamic acid on mortality according to baseline risk: a secondary analysis of a randomised controlled trial. Perel P, Prieto-Merino D, Shakur H, Roberts I. Health Technol Assess; 2013 Jun; 17(24):1-45, v-vi. PubMed ID: 23782457 [Abstract] [Full Text] [Related]
9. Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial. Roberts I, Perel P, Prieto-Merino D, Shakur H, Coats T, Hunt BJ, Lecky F, Brohi K, Willett K, CRASH-2 Collaborators. BMJ; 2012 Sep 11; 345():e5839. PubMed ID: 22968527 [Abstract] [Full Text] [Related]
10. Efficacy of FDA-approved hemostatic drugs to improve survival and reduce bleeding in rat models of uncontrolled hemorrhage. Ryan KL, Cortez DS, Dick EJ, Pusateri AE. Resuscitation; 2006 Jul 11; 70(1):133-44. PubMed ID: 16757085 [Abstract] [Full Text] [Related]
11. Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial. Roberts I, Prieto-Merino D, Manno D. Crit Care; 2014 Dec 13; 18(6):685. PubMed ID: 25498484 [Abstract] [Full Text] [Related]
12. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. CRASH-2 trial collaboratorsClinical Trials Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK., Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. Lancet; 2010 Jul 03; 376(9734):23-32. PubMed ID: 20554319 [Abstract] [Full Text] [Related]
13. Does the use of tranexamic acid improve trauma mortality? Harvey V, Perrone J, Kim P. Ann Emerg Med; 2014 Apr 03; 63(4):460-2. PubMed ID: 24095056 [No Abstract] [Full Text] [Related]
14. Intravenous tranexamic acid use in myomectomy: a prospective randomized double-blind placebo controlled study. Caglar GS, Tasci Y, Kayikcioglu F, Haberal A. Eur J Obstet Gynecol Reprod Biol; 2008 Apr 03; 137(2):227-31. PubMed ID: 17499419 [Abstract] [Full Text] [Related]
15. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial. Later AF, Maas JJ, Engbers FH, Versteegh MI, Bruggemans EF, Dion RA, Klautz RJ. Eur J Cardiothorac Surg; 2009 Aug 03; 36(2):322-9. PubMed ID: 19250838 [Abstract] [Full Text] [Related]
16. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. CRASH-2 collaboratorsClinical Trials Unit, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK. crash@lshtm.ac.uk, Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T. Lancet; 2011 Mar 26; 377(9771):1096-101, 1101.e1-2. PubMed ID: 21439633 [Abstract] [Full Text] [Related]
17. Tranexamic acid in trauma: how should we use it? Roberts I. J Thromb Haemost; 2015 Jun 26; 13 Suppl 1():S195-9. PubMed ID: 26149023 [Abstract] [Full Text] [Related]
18. A nested mechanistic sub-study into the effect of tranexamic acid versus placebo on intracranial haemorrhage and cerebral ischaemia in isolated traumatic brain injury: study protocol for a randomised controlled trial (CRASH-3 Trial Intracranial Bleeding Mechanistic Sub-Study [CRASH-3 IBMS]). Mahmood A, Roberts I, Shakur H. Trials; 2017 Jul 17; 18(1):330. PubMed ID: 28716153 [Abstract] [Full Text] [Related]
19. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. CRASH-3 trial collaborators. Lancet; 2019 Nov 09; 394(10210):1713-1723. PubMed ID: 31623894 [Abstract] [Full Text] [Related]
20. Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study. Wang G, Xie G, Jiang T, Wang Y, Wang W, Ji H, Liu M, Chen L, Li L. Anesth Analg; 2012 Aug 09; 115(2):239-43. PubMed ID: 21737704 [Abstract] [Full Text] [Related] Page: [Next] [New Search]